MrC's Smallcap Sweeps for Jan 2024
Posted: January 2nd, 2024, 7:48 am
Smallcap Sweep. 02-Jan-24
What's the score in '24?
Tan Delta Systems (TAND) another recent IPO (Aug) stiffs holders. Warns FY-Dec rev down c. 10%, below original management expectations. Blames customers delaying trials. Adj net loss broadly in line at c. £0.4m due to slow recruitment of new staff. Outlook: "we look forward to 2024 with great optimism". Why am I not reassured? [SP=21 Cap=17m]
Dialight (DIA) Sanmina litigation: court denied Sanmina's motion to dismiss Dialight's fraudulent inducement claim. Also court affirmed its prior opinion and denied Sanmina's motion for summary judgment on its accounts receivable claim. [SP=140.84 Cap=59m]
Jade Road Investments (JADE) proposed disposal of legacy Asian assets, restructuring exercise and strategic direction. Legacy assets will be moved into an SPV which will then be given to shareholders in specie. The some loan note rigmarole. Smells. [SP=1.75 Cap=7m]
Angle (AGL) $250k contract for pilot study for co's Portrait HER2 assay. [SP=11.7 Cap=31m]
LungLife AI (LLAI) validation of LungLB in multi-site, prospective clinical study. "LungLB performed strongly in participants with smaller lung nodules." [SP=50 Cap=12m]
Plant Health Care (PHC) Brazil approves TEIKKO to control nematodes in soybeans. [SP=3.4 Cap=13m]
Plexus (POS) $5.2m perpetual P Licence Agreement with SLB replacing an existing surface production wellhead licence. [SP=20.9 Cap=22m]
hVIVO (HVO) £6.3m contract to start H2 2024, with revenue recognised in 2024 and 2025. [SP=23.93 Cap=162m]
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
What's the score in '24?
Tan Delta Systems (TAND) another recent IPO (Aug) stiffs holders. Warns FY-Dec rev down c. 10%, below original management expectations. Blames customers delaying trials. Adj net loss broadly in line at c. £0.4m due to slow recruitment of new staff. Outlook: "we look forward to 2024 with great optimism". Why am I not reassured? [SP=21 Cap=17m]
Dialight (DIA) Sanmina litigation: court denied Sanmina's motion to dismiss Dialight's fraudulent inducement claim. Also court affirmed its prior opinion and denied Sanmina's motion for summary judgment on its accounts receivable claim. [SP=140.84 Cap=59m]
Jade Road Investments (JADE) proposed disposal of legacy Asian assets, restructuring exercise and strategic direction. Legacy assets will be moved into an SPV which will then be given to shareholders in specie. The some loan note rigmarole. Smells. [SP=1.75 Cap=7m]
Angle (AGL) $250k contract for pilot study for co's Portrait HER2 assay. [SP=11.7 Cap=31m]
LungLife AI (LLAI) validation of LungLB in multi-site, prospective clinical study. "LungLB performed strongly in participants with smaller lung nodules." [SP=50 Cap=12m]
Plant Health Care (PHC) Brazil approves TEIKKO to control nematodes in soybeans. [SP=3.4 Cap=13m]
Plexus (POS) $5.2m perpetual P Licence Agreement with SLB replacing an existing surface production wellhead licence. [SP=20.9 Cap=22m]
hVIVO (HVO) £6.3m contract to start H2 2024, with revenue recognised in 2024 and 2025. [SP=23.93 Cap=162m]
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian